Abstract
The role of therapeutic reductive lymphapheresis in 59 patients with chronic lymphocytic leukemia (CLL) was reviewed. Reduction in lymphocytosis, lymphadenopathy and hepatosplenomegaly was noted in 50%–60% of the patients studied. In addition to mobilization of the lymphoid tumor load, 40% of the patients showed an improvement in their hemogram. Although apheresis‐induced anemia can occur, reported complications were minimal. These studies suggest that a majority of CLL patients might benefit from therapeutic lymphapheresis.
Original language | English (US) |
---|---|
Pages (from-to) | 243-248 |
Number of pages | 6 |
Journal | Journal of Clinical Apheresis |
Volume | 1 |
Issue number | 4 |
DOIs | |
State | Published - 1983 |
Keywords
- CLL
- lymphapheresis
- therapeutic
ASJC Scopus subject areas
- Hematology